Transthyretin amyloidosis, ATTR

Transthyretin amyloidosis, ATTR

Transthyretin amyloidosis, ATTR, (NCT04601051)
Sponsors:
Intellia Therapeutics
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine